PODD(Insulet Corporation) 的财务报表:医疗保健,医疗器械。数据来自 SEC 公开申报与市场行情,不构成投资建议。
| 科目 | FY 截至 2021-12-31 | FY 截至 2022-12-31 | FY 截至 2023-12-31 | FY 截至 2024-12-31 | FY 截至 2025-12-31 |
|---|---|---|---|---|---|
| 营业收入 | $1.10B | $1.31B | $1.70B | $2.07B | $2.71B |
| 毛利润 | $752.10M | $805.60M | $1.16B | $1.45B | $1.94B |
| 营业利润 | $126.00M | $37.60M | $220.10M | $308.90M | $473.80M |
| 净利润 | $16.80M | $4.60M | $206.30M | $418.30M | $247.10M |
| 经营现金流 | −$68.10M | $119.00M | $145.70M | $430.20M | $569.30M |
| 自由现金流 | −$180.00M | −$3.90M | $70.10M | $305.30M | $377.70M |
| 摊薄每股收益 | $0.24 | $0.07 | $2.94 | $5.78 | $3.48 |